MD Anderson Cancer Center, Department of Leukemia — Houston, Texas

MD Anderson Cancer Center, Department of Leukemia is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center, Department of Leukemia has participated in 2 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis.

Sponsors: NS Pharma, Inc., MingSight Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center, Department of Leukemia?

MD Anderson Cancer Center, Department of Leukemia has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center, Department of Leukemia conducted?

MD Anderson Cancer Center, Department of Leukemia has 2 clinical trials on record. Their work covers Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis.

Is MD Anderson Cancer Center, Department of Leukemia accredited by Crixeo Health?

MD Anderson Cancer Center, Department of Leukemia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center, Department of Leukemia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.